192 related articles for article (PubMed ID: 36432602)
1. NAPRT, but Not NAMPT, Provides Additional Support for NAD Synthesis in Esophageal Precancerous Lesions.
Wang N; Pan D; Wang X; Su M; Wang X; Yan Q; Sun G; Wang S
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432602
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic Acid Phosphoribosyltransferase Regulates Cancer Cell Metabolism, Susceptibility to NAMPT Inhibitors, and DNA Repair.
Piacente F; Caffa I; Ravera S; Sociali G; Passalacqua M; Vellone VG; Becherini P; Reverberi D; Monacelli F; Ballestrero A; Odetti P; Cagnetta A; Cea M; Nahimana A; Duchosal M; Bruzzone S; Nencioni A
Cancer Res; 2017 Jul; 77(14):3857-3869. PubMed ID: 28507103
[TBL] [Abstract][Full Text] [Related]
3. NAD Synthesis Pathway Interference Is a Viable Therapeutic Strategy for Chondrosarcoma.
Peterse EFP; van den Akker BEWM; Niessen B; Oosting J; Suijker J; de Jong Y; Danen EHJ; Cleton-Jansen AM; Bovée JVMG
Mol Cancer Res; 2017 Dec; 15(12):1714-1721. PubMed ID: 28860121
[TBL] [Abstract][Full Text] [Related]
4. Non-canonical roles of NAMPT and PARP in inflammation.
Martínez-Morcillo FJ; Cantón-Sandoval J; Martínez-Menchón T; Corbalán-Vélez R; Mesa-Del-Castillo P; Pérez-Oliva AB; García-Moreno D; Mulero V
Dev Comp Immunol; 2021 Feb; 115():103881. PubMed ID: 33038343
[TBL] [Abstract][Full Text] [Related]
5. Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors.
Duarte-Pereira S; Pereira-Castro I; Silva SS; Correia MG; Neto C; da Costa LT; Amorim A; Silva RM
Oncotarget; 2016 Jan; 7(2):1973-83. PubMed ID: 26675378
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of NAD
Ghanem MS; Caffa I; Monacelli F; Nencioni A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396769
[TBL] [Abstract][Full Text] [Related]
7. A Versatile Continuous Fluorometric Enzymatic Assay for Targeting Nicotinate Phosphoribosyltransferase.
Minazzato G; Marangoni E; Fortunato C; Petrelli R; Cappellacci L; Del Bello F; Sorci L; Gasparrini M; Piacente F; Bruzzone S; Raffaelli N
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770640
[TBL] [Abstract][Full Text] [Related]
8. NAMPT-derived NAD+ fuels PARP1 to promote skin inflammation through parthanatos cell death.
Martínez-Morcillo FJ; Cantón-Sandoval J; Martínez-Navarro FJ; Cabas I; Martínez-Vicente I; Armistead J; Hatzold J; López-Muñoz A; Martínez-Menchón T; Corbalán-Vélez R; Lacal J; Hammerschmidt M; García-Borrón JC; García-Ayala A; Cayuela ML; Pérez-Oliva AB; García-Moreno D; Mulero V
PLoS Biol; 2021 Nov; 19(11):e3001455. PubMed ID: 34748530
[TBL] [Abstract][Full Text] [Related]
9. A decrease in NAMPT activity impairs basal PARP-1 activity in cytidine deaminase deficient-cells, independently of NAD
Silveira SC; Buhagiar-Labarchède G; Onclercq-Delic R; Gemble S; Bou Samra E; Mameri H; Duchambon P; Machon C; Guitton J; Amor-Guéret M
Sci Rep; 2020 Aug; 10(1):13907. PubMed ID: 32807821
[TBL] [Abstract][Full Text] [Related]
10. Supplementation of nicotinic acid with NAMPT inhibitors results in loss of in vivo efficacy in NAPRT1-deficient tumor models.
O'Brien T; Oeh J; Xiao Y; Liang X; Vanderbilt A; Qin A; Yang L; Lee LB; Ly J; Cosino E; LaCap JA; Ogasawara A; Williams S; Nannini M; Liederer BM; Jackson P; Dragovich PS; Sampath D
Neoplasia; 2013 Dec; 15(12):1314-29. PubMed ID: 24403854
[TBL] [Abstract][Full Text] [Related]
11. NAMPT and NAPRT, Key Enzymes in NAD Salvage Synthesis Pathway, Are of Negative Prognostic Value in Colorectal Cancer.
Li XQ; Lei J; Mao LH; Wang QL; Xu F; Ran T; Zhou ZH; He S
Front Oncol; 2019; 9():736. PubMed ID: 31448236
[TBL] [Abstract][Full Text] [Related]
12. Novel NAPRT specific antibody identifies small cell lung cancer and neuronal cancers as promising clinical indications for a NAMPT inhibitor/niacin co-administration strategy.
Cole J; Guiot MC; Gravel M; Bernier C; Shore GC; Roulston A
Oncotarget; 2017 Sep; 8(44):77846-77859. PubMed ID: 29100430
[TBL] [Abstract][Full Text] [Related]
13. Synthetic lethality of PARP and NAMPT inhibition in triple-negative breast cancer cells.
Bajrami I; Kigozi A; Van Weverwijk A; Brough R; Frankum J; Lord CJ; Ashworth A
EMBO Mol Med; 2012 Oct; 4(10):1087-96. PubMed ID: 22933245
[TBL] [Abstract][Full Text] [Related]
14. Restoring NAD
Katayoshi T; Nakajo T; Tsuji-Naito K
J Photochem Photobiol B; 2021 Aug; 221():112238. PubMed ID: 34130091
[TBL] [Abstract][Full Text] [Related]
15. Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue.
Rappou E; Jukarainen S; Rinnankoski-Tuikka R; Kaye S; Heinonen S; Hakkarainen A; Lundbom J; Lundbom N; Saunavaara V; Rissanen A; Virtanen KA; Pirinen E; Pietiläinen KH
J Clin Endocrinol Metab; 2016 Mar; 101(3):1263-73. PubMed ID: 26760174
[TBL] [Abstract][Full Text] [Related]
16. NAMPT and NAMPT-controlled NAD Metabolism in Vascular Repair.
Wang P; Li WL; Liu JM; Miao CY
J Cardiovasc Pharmacol; 2016 Jun; 67(6):474-81. PubMed ID: 26485210
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel NAMPT inhibitor that selectively targets NAPRT-deficient EMT-subtype cancer cells and alleviates chemotherapy-induced peripheral neuropathy.
Kim M; Kim H; Kang BG; Lee J; Kim T; Lee H; Jung J; Oh MJ; Seo S; Ryu MJ; Sung Y; Lee Y; Yeom J; Han G; Cha SS; Jung H; Kim HS
Theranostics; 2023; 13(14):5075-5098. PubMed ID: 37771778
[No Abstract] [Full Text] [Related]
18. Nuclear transport of nicotinamide phosphoribosyltransferase is cell cycle-dependent in mammalian cells, and its inhibition slows cell growth.
Svoboda P; Krizova E; Sestakova S; Vapenkova K; Knejzlik Z; Rimpelova S; Rayova D; Volfova N; Krizova I; Rumlova M; Sykora D; Kizek R; Haluzik M; Zidek V; Zidkova J; Skop V
J Biol Chem; 2019 May; 294(22):8676-8689. PubMed ID: 30975903
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas.
Olesen UH; Hastrup N; Sehested M
APMIS; 2011 Apr; 119(4-5):296-303. PubMed ID: 21492230
[TBL] [Abstract][Full Text] [Related]
20. Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors.
Chini CC; Guerrico AM; Nin V; Camacho-Pereira J; Escande C; Barbosa MT; Chini EN
Clin Cancer Res; 2014 Jan; 20(1):120-30. PubMed ID: 24025713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
